Gene Expression Testing
Assays, which are tests to uncover the types of genes that cancer expresses, have permitted healthcare physicians to craft effective therapies based on a person's individual needs. Breast cancer specialists are utilizing two assays, Oncotype DXÂ® and MammaPrintÂ®, to better determine a woman's risk of any recurrence or metastasis (the spread) based upon varying genes cancer expresses, through a process called gene subtyping. From here, they can better plan treatments to reduce these risks effectively. These tests can also assist in finding out who is more likely to benefit from treatments with chemotherapy in addition to hormone therapy.
Continue reading to learn about an advancement made in chemotherapy for treating breast cancer.